This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen in a 2 ml size. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $16,377.16 and has an ultimate completion date of December 31, 2024.
The contract is not designated as a set-aside and was awarded by the Defense Logistics Agency (DLA), a defense agency. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a discrete order against that larger IDC.
Generated 3/31/25, 9:39 AM